Literature DB >> 19059323

Development of tablets containing probiotics: Effects of formulation and processing parameters on bacterial viability.

Srikanjana Klayraung1, Helmut Viernstein, Siriporn Okonogi.   

Abstract

The probiotic products available in the market nowadays are mostly in the form of liquid or semisolid formulations which show low cell viability after oral administration, mainly because the bacteria do not survive the harsh conditions in the stomach. The development of suitable dry dosage forms enable higher bacterial survival and consequently is the main aim of the present study. An anticipated advantage is that due to the low water-activity lyophilized bacterial cells will preserve their viability. Further, by a proper selection of a tablet forming matrix, it is foreseen that the entrapped bacteria are protected against the low pH in the stomach. In this study, the effects on bacterial survival in tablets were investigated concerning compression force, matrix forming excipients such as hydroxypropyl methylcellulose phthalate (HPMCP) or other swelling agents. The results showed that the proportion of matrix forming excipients in tablets and the compression force affected the properties of probiotic tablets in terms of tensile strength and disintegration as well as the survival of the bacteria. The tensile strength of the tablets increased with increase of HPMCP content. Tablets manufactured with high compression force showed a slow disintegration time and high bacterial cell viability (more than 80%). Incorporation of sodium alginate in the tablets resulted in higher cell survival in simulated GI fluid (>90%) and a suitable disintegration time (approximately 5h). By a proper design of the formulation, tablets with a fast disintegration time and a high preservation of bacterial cell viability were developed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059323     DOI: 10.1016/j.ijpharm.2008.11.004

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans.

Authors:  Stéphanie Blanquet-Diot; Sylvain Denis; Sandrine Chalancon; Fehd Chaira; Jean-Michel Cardot; Monique Alric
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

Review 2.  A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.

Authors:  Mershen Govender; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Sandy van Vuuren; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-09-25       Impact factor: 3.246

Review 3.  Insights on the Critical Parameters Affecting the Probiotic Viability During Stabilization Process and Formulation Development.

Authors:  Sharda Gurram; Durgesh K Jha; Devanshi S Shah; Madhuri M Kshirsagar; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2021-05-18       Impact factor: 3.246

4.  Development of probiotic tablets using microparticles: viability studies and stability studies.

Authors:  J P Sousa e Silva; Sérgio C Sousa; Paulo Costa; Emília Cerdeira; Maria H Amaral; José Sousa Lobo; Ana M Gomes; Maria M Pintado; Dina Rodrigues; Teresa Rocha-Santos; Ana C Freitas
Journal:  AAPS PharmSciTech       Date:  2012-12-12       Impact factor: 3.246

5.  The influence of different polymers on viability of Bifidobacterium lactis 300b during encapsulation, freeze-drying and storage.

Authors:  Oana Lelia Pop; Thorsten Brandau; Jens Schwinn; Dan Cristian Vodnar; Carmen Socaciu
Journal:  J Food Sci Technol       Date:  2014-07-08       Impact factor: 2.701

6.  Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect.

Authors:  Hee Jun Park; Ga Hyeon Lee; Joonho Jun; Miwon Son; Myung Joo Kang
Journal:  Drug Des Devel Ther       Date:  2016-04-07       Impact factor: 4.162

7.  Stability evaluation of freeze-dried Lactobacillus paracasei subsp. tolerance and Lactobacillus delbrueckii subsp. bulgaricus in oral capsules.

Authors:  M Jalali; D Abedi; J Varshosaz; M Najjarzadeh; M Mirlohi; N Tavakoli
Journal:  Res Pharm Sci       Date:  2012-01

8.  Effects of processing and storage on Pediococcus pentosaceus SB83 in vaginal formulations: lyophilized powder and tablets.

Authors:  Sandra Borges; Paulo Costa; Joana Silva; Paula Teixeira
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411

Review 9.  Biofilm Forming Lactobacillus: New Challenges for the Development of Probiotics.

Authors:  María José Salas-Jara; Alejandra Ilabaca; Marco Vega; Apolinaria García
Journal:  Microorganisms       Date:  2016-09-20

10.  Along the Process Chain to Probiotic Tablets: Evaluation of Mechanical Impacts on Microbial Viability.

Authors:  Karl Vorländer; Ingo Kampen; Jan Henrik Finke; Arno Kwade
Journal:  Pharmaceutics       Date:  2020-01-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.